- Home
- FEMY vs ANVS Comparison
FEMY vs ANVS Comparison
Compare FEMY & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEMY
- ANVS
- Stock Information
- Founded
- FEMY 2004
- ANVS 2008
- Country
- FEMY United States
- ANVS United States
- Employees
- FEMY N/A
- ANVS N/A
- Industry
- FEMY Medical/Dental Instruments
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- FEMY Health Care
- ANVS Health Care
- Exchange
- FEMY Nasdaq
- ANVS Nasdaq
- Market Cap
- FEMY N/A
- ANVS 24.2M
- IPO Year
- FEMY 2021
- ANVS 2020
- Fundamental
- Price
- FEMY $1.23
- ANVS $1.57
- Analyst Decision
- FEMY Strong Buy
- ANVS Strong Buy
- Analyst Count
- FEMY 2
- ANVS 5
- Target Price
- FEMY $11.50
- ANVS $37.00
- AVG Volume (30 Days)
- FEMY 233.4K
- ANVS 453.8K
- Earning Date
- FEMY 05-08-2025
- ANVS 05-12-2025
- Dividend Yield
- FEMY N/A
- ANVS N/A
- EPS Growth
- FEMY N/A
- ANVS N/A
- EPS
- FEMY N/A
- ANVS N/A
- Revenue
- FEMY $1,629,108.00
- ANVS N/A
- Revenue This Year
- FEMY $441.89
- ANVS N/A
- Revenue Next Year
- FEMY $101.29
- ANVS N/A
- P/E Ratio
- FEMY N/A
- ANVS N/A
- Revenue Growth
- FEMY 51.97
- ANVS N/A
- 52 Week Low
- FEMY $0.86
- ANVS $1.11
- 52 Week High
- FEMY $1.80
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- FEMY 47.30
- ANVS 50.94
- Support Level
- FEMY $1.07
- ANVS $1.19
- Resistance Level
- FEMY $1.29
- ANVS $1.68
- Average True Range (ATR)
- FEMY 0.09
- ANVS 0.17
- MACD
- FEMY 0.02
- ANVS 0.07
- Stochastic Oscillator
- FEMY 73.91
- ANVS 76.67
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.